RAC continues to defy the rest of the Industry and continues to look after Retail Holders.
Not only is Zantrene looking like a Lifechanging drug, the company for Shareholders is too.
EVERY SINGLE Other company I am invested in, very soon after (or even before) the good news comes out to cause a rerate... they are doing a Discounted Capraise to their Soph and Insto mates, stealing 15-20% of the potential profit that Retail holders would have received.
But not RAC, again and again they are trying to find ways to reward the loyal holders, whether it be the ones who hold $200k of stock, or $1k...
To the RACE Board - THANK YOU for giving us the chance to get ahead!
RAC 2021 AGM Discussion, page-46
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.030(2.01%) |
Mkt cap ! $254.2M | |||
| Open | High | Low | Value | Volume |
| $1.51 | $1.53 | $1.48 | $141.7K | 94.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 427 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 2999 | 2 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.51 |
Change
0.030 ( 0.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.52 | $1.53 | $1.48 | 13236 | ||
| Last updated 15.53pm 21/05/2024 ? | |||||
| RAC (ASX) Chart |